Document is current

Article History

Received: 1 June 2022

Accepted: 9 September 2022

First Online: 24 September 2022

Declarations

:

: The study received ethical approval from the South West – Frenchay Research Ethics Committee (committee reference number 19/SW/0235) prior to its conduct. All methods were carried out in accordance with the Declaration of Helsinki and all other relevant regulations and guidelines. The first page of the questionnaire informed participants that to take part in the study, they were required to read and tick each of four statements indicating that they: (i) had read the relevant version of the Participant Information Sheet and had the opportunity to ask questions and have these answered fully; (ii) understood that their participation was voluntary; (iii) understood that the data they provided could be stored and used in its anonymised form for reports, publications, and/or teaching materials from the research and by other researchers for other research; (iv) agreed to take part in the study. Informed consent was obtained from all participants. Contact details for the study team were included in the study invitation letter to give patients the opportunity to ask questions before participating. Personally identifiable data will not be shared outside the study team.

: Not applicable.

: The authors declare that they have no competing interests.